Bioremediation of Endocrine Disruptors (EDs): A Systematic Review of Fungal Application in ED Removal from Wastewater
Abstract
Endocrine disruptors (EDs), including natural estrogens, such as 17β-estradiol (E2) and synthetic chemicals (e.g., bisphenol A (BPA) and per- and polyfluoroalkyl substances (PFAS)), pose environmental and human health risks due to their ability to interfere with hormonal systems, even at trace concentrations and can lead to developmental, reproductive, and carcinogenic effects. These persistent compounds often escape removal in conventional wastewater treatment processes, leading to environmental contamination and human exposure. Given their widespread presence in wastewater and resistance to conventional treatments, the use of fungi offers a promising bioremediation strategy. This review explores the potential of fungal biodegradation, particularly using the white-rot fungus Trametes versicolor, in mitigating the estrogenic activity of EDs in wastewater. Laccase, an oxidative enzyme produced by white-rot fungus, shows high efficiency in degrading EDs, positioning fungal treatment as an eco-friendly alternative to conventional technologies. This systematic literature review was conducted using the Methodi Ordinatio, a multi-criteria decision-making methodology that allows for a structured selection of relevant studies and underscores the significant potential of fungal-based systems in addressing the global challenge of ED contamination in water environments.
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.